blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3058374

EP3058374 - METHOD FOR DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  24.05.2019
FormerGrant of patent is intended
Status updated on  31.01.2019
FormerExamination is in progress
Status updated on  03.08.2018
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Attoquant Diagnostics GmbH
Campus-Vienna-Biocenter 5
1030 Vienna / AT
[2016/34]
Inventor(s)01 / POGLITSCH, Marko
Wilhelminenstrasse 74/46
1160 Vienna / AT
02 / SCHWAGER, Cornelia
Kollergasse 9/1/5
1030 Vienna / AT
03 / VAN OYEN, Dunja
Buchengasse 155/1/120
1100 Vienna / AT
04 / LEITNER, Martin
Harmsdorfgasse 48b/7
8042 Graz / AT
 [2019/26]
Former [2016/34]01 / POGLITSCH, Marko
Wilhelminenstrasse 74/46
1160 Vienna / AT
02 / SCHWAGER, Cornelia
Kollergasse 9/1/5
1030 Vienna / AT
03 / VAN OYEN, Dunja
Buchengasse 155/1/120
1100 Vienna / AT
04 / LEITNER, Martin
Harmsdorfgasse 48B/7
8042 Graz / AT
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2016/34]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date14789218.617.10.2014
[2016/34]
WO2014EP72339
Priority number, dateEP2013018938618.10.2013         Original published format: EP 13189386
EP2014015276328.01.2014         Original published format: EP 14152763
[2016/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015055825
Date:23.04.2015
Language:EN
[2015/16]
Type: A1 Application with search report 
No.:EP3058374
Date:24.08.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 23.04.2015 takes the place of the publication of the European patent application.
[2016/34]
Type: B1 Patent specification 
No.:EP3058374
Date:26.06.2019
Language:EN
[2019/26]
Search report(s)International search report - published on:EP23.04.2015
ClassificationIPC:G01N33/74
[2016/34]
CPC:
G01N33/74 (EP,EA,US); G01N33/743 (EA,US); A61K31/165 (EP,EA,US);
A61K31/401 (EP,EA,US); A61K31/4178 (EP,EA,US); A61P5/38 (EP,EA);
G01N33/492 (EP,EA,US); G01N2333/723 (EP,EA,US); G01N2410/02 (EP,EA,US);
G01N2800/04 (EP,EA,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/34]
Extension statesBA13.04.2016
ME13.04.2016
TitleGerman:VERFAHREN ZUR DIAGNOSE VON PRIMÄREM HYPERALDOSTERONISMUS[2016/34]
English:METHOD FOR DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM[2016/34]
French:PROCÉDÉ DE DIAGNOSTIC D'HYPERALDOSTÉRONISME PRIMAIRE[2016/34]
Entry into regional phase13.04.2016National basic fee paid 
13.04.2016Designation fee(s) paid 
13.04.2016Examination fee paid 
Examination procedure13.04.2016Amendment by applicant (claims and/or description)
13.04.2016Examination requested  [2016/34]
03.08.2018Despatch of a communication from the examining division (Time limit: M04)
29.11.2018Reply to a communication from the examining division
01.02.2019Communication of intention to grant the patent
15.05.2019Fee for grant paid
15.05.2019Fee for publishing/printing paid
15.05.2019Receipt of the translation of the claim(s)
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
11.10.2016Renewal fee patent year 03
09.10.2017Renewal fee patent year 04
08.10.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL26.06.2019
CY26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
MK26.06.2019
MT26.06.2019
RO26.06.2019
RS26.06.2019
SI26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
IS26.10.2019
PT28.10.2019
[2022/31]
Former [2021/34]AL26.06.2019
CY26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
MT26.06.2019
RO26.06.2019
RS26.06.2019
SI26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
IS26.10.2019
PT28.10.2019
Former [2021/26]AL26.06.2019
CY26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
RO26.06.2019
RS26.06.2019
SI26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
IS26.10.2019
PT28.10.2019
Former [2020/37]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
RO26.06.2019
RS26.06.2019
SI26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
IS26.10.2019
PT28.10.2019
Former [2020/36]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
IS26.10.2019
PT28.10.2019
Former [2020/35]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
LU17.10.2019
PT28.10.2019
IS24.02.2020
Former [2020/29]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
MC26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
PT28.10.2019
IS24.02.2020
Former [2020/24]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
PT28.10.2019
IS24.02.2020
Former [2020/17]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
TR26.06.2019
BG26.09.2019
GR27.09.2019
IS26.10.2019
PT28.10.2019
Former [2020/14]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
SM26.06.2019
BG26.09.2019
GR27.09.2019
IS26.10.2019
PT28.10.2019
Former [2020/12]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
BG26.09.2019
GR27.09.2019
IS26.10.2019
PT28.10.2019
Former [2020/11]AL26.06.2019
EE26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
SK26.06.2019
BG26.09.2019
GR27.09.2019
PT28.10.2019
Former [2020/10]AL26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RO26.06.2019
RS26.06.2019
BG26.09.2019
GR27.09.2019
PT28.10.2019
Former [2019/51]AL26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RS26.06.2019
BG26.09.2019
GR27.09.2019
Former [2019/50]AL26.06.2019
HR26.06.2019
LT26.06.2019
LV26.06.2019
RS26.06.2019
GR27.09.2019
Former [2019/47]LT26.06.2019
Cited inInternational search[XI]  - KATO M ET AL, "Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure", JOURNAL OF CARDIAL FAILURE, CHURCHILL LIVINGSTONE, NAPERVILLE, IL, US, (19960601), vol. 2, no. 2, doi:10.1016/S1071-9164(96)80028-5, ISSN 1071-9164, pages 103 - 110, XP004680556 [X] 15,16,18 * abstract * [I] 17

DOI:   http://dx.doi.org/10.1016/S1071-9164(96)80028-5
 [XA]  - LIM PITT O ET AL, "The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?", JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, LTD, US / UK, (20020101), vol. 20, no. 1, ISSN 0263-6352, pages 11 - 15, XP009174679 [X] 1 * abstract * * page 13, column l, paragraph 1; figure 2 * [A] 2-15

DOI:   http://dx.doi.org/10.1097/00004872-200201000-00003
 [XI]  - WISGERHOF M ET AL, "Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (19781101), vol. 47, no. 5, ISSN 0021-972X, pages 938 - 943, XP009174704 [X] 1,2,4,11,14,18 * abstract * * page 942, column r, paragraph l * [I] 3,5-10,12,13,15-17

DOI:   http://dx.doi.org/10.1210/jcem-47-5-938
 [A]  - MCKENNA T J ET AL, "Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, (19911101), vol. 73, no. 5, ISSN 0021-972X, pages 952 - 957, XP009174678 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1210/jcem-73-5-952
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.